Abcuro
Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
$66MSeries D
Role not disclosedLoading investors…
Activity from announced rounds
Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
Runs autonomous AI-driven penetration testing to secure enterprise networks
Relationship intelligence platform for enterprise revenue teams
Developing AI systems to discover and design new materials for clean energy and chipmaking
A leading food technology platform built to make great food more accessible
Building the sovereign infrastructure layer for high-consequence operations and AI-driven systems
Building a safer world by deploying low-cost air defense systems at scale
Provides real-time and historical market data across futures, options, and equities through a unified API